The Lancet Respiratory Medicine 今日热榜



The Lancet Respiratory Medicine The Lancet Respiratory Medicine

1.	[Comment] Serotonin pathway blockade in pulmonary arterial hypertension	Marcin Kurzyna	
2.	[Articles] Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial	Olivier Sitbon, Andris Skride, Jeremy Feldman, Sandeep Sahay, Oksana A Shlobin, Vallerie McLaughlin, Hossein-Ardeschir Ghofrani, David Langleben, Ed Parsley, Gwyn D'Souza, Tonya Marmon, Watiri Kamau-Kelley, Renee Jones, Ravi Grewal, Steve Wring, Michelle Palacios, Himanshu Naik, Jill Denning, Howard M Lazarus, Marc Humbert	
3.	[Articles] Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial	Ze-Rui Zhao, Shi-Liang Liu, Ting Zhou, Gang Chen, Hao Long, Xiao-Dong Su, Xu Zhang, Jian-Hua Fu, Peng Lin, Lan-Jun Zhang, Tie-Hua Rong, Jia-Di Wu, Zhi-Chao Li, Hui-Lin Su, Ji-Yang Chen, Yun-Peng Yang, Yong-Bin Lin, Mian Xi, Hong Yang	
4.	[Comment] Stereotactic body radiotherapy plus neoadjuvant chemoimmunotherapy in operable non-small-cell lung cancer	Rafał Dziadziuszko, Bartłomiej Tomasik	
5.	[Editorial] Extreme heat: holistic thinking in respiratory medicine	The Lancet Respiratory Medicine	
6.	[Correspondence] Top ten research priorities for sepsis research: UK James Lind Alliance priority setting partnership	Joanne McPeake, Mark Oakes, Colin Graham, Nahid Ahmad, Nazir Lone, Bronwen Connolly, James Lind Alliance Sepsis PSP Steering Group	
7.	[Articles] Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory study	Yongfeng Yu, Qisen Guo, Yongchang Zhang, Jian Fang, Diansheng Zhong, Baogang Liu, Pinhua Pan, Dongqing Lv, Lin Wu, Yanqiu Zhao, Juan Li, Zhihua Liu, Chunling Liu, Haichuan Su, Yun Fan, Tongmei Zhang, Anwen Liu, Bo Jin, Ye Wang, Jianying Zhou, Zhihong Zhang, Fengming Ran, Xia Song, Michael Shi, Weiguo Su, Shun Lu, study group	
8.	[Comment] Savolitinib in NSCLC: progress in the MET exon 14 journey	Tetsuya Mitsudomi	
9.	[Articles] Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months	Charles S Haworth, Michal Shteinberg, Kevin Winthrop, Alan Barker, Francesco Blasi, Katerina Dimakou, Lucy C Morgan, Anne E O'Donnell, Felix C Ringshausen, Oriol Sibila, Rachel M Thomson, Kevin J Carroll, Federica Pontenani, Paola Castellani, James D Chalmers, PROMIS trial investigators	
10.	[Comment] PROMISing results for inhaled antibiotics in bronchiectasis	Marta María García Clemente, Guillermo Suárez Cuartín	
11.	[Comment] Plinabulin, a microtubule destabilising agent, in non-small-cell lung cancer: lessons from the DUBLIN-3 trial	Rafael Rosell, María González-Cao, Miguel Angel Molina-Vila	
12.	[Articles] Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial	Baohui Han, Trevor Feinstein, Yuankai Shi, Gongyan Chen, Yu Yao, Chunhong Hu, Jianhua Shi, Jifeng Feng, Huijuan Wu, Ying Cheng, Qi-sen Guo, Zhijun Jie, Feng Ye, Yiping Zhang, Zhihua Liu, Weidong Mao, Liangming Zhang, Junguo Lu, Jun Zhao, Lyudmila Bazhenova, Jimmy Ruiz, Goetz H Kloecker, Kalmadi R Sujith, Ira A Oliff, Matthew Wong, Bin Liu, Yanping Wu, Lan Huang, Yan Sun, DUBLIN-3 study group	
13.	[Articles] Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial	Irene J Higginson, Sarah T Brown, Adejoke O Oluyase, Peter May, Matthew Maddocks, Massimo Costantini, Sabrina Bajwah, Charles Normand, Claudia Bausewein, Steffen T Simon, Karen Ryan, David C Currow, Miriam J Johnson, Simon P Hart, Hannah Mather, Malgorzata Krajnik, Silvia Tanzi, Luca Ghirotto, Charlotte E Bolton, Piotr Janowiak, Elena Turola, Caroline J Jolley, Geraldine Murden, Andrew Wilcock, Bobbie Farsides, Julia M Brown, BETTER-B consortium	
14.	[Comment] The ongoing battle against breathlessness	Kris Mooren, Huib A M Kerstjens	
15.	[Comment] Choice overload for RSV prevention—how to form your opinion	Natasha Halasa, Louis Bont	
16.	[Series] Respiratory syncytial virus infections in adults: a narrative review	Joanne G Wildenbeest, David M Lowe, Joseph F Standing, Christopher C Butler	
17.	[Series] Early-life respiratory syncytial virus disease and long-term respiratory health	Heather J Zar, Ferdinand Cacho, Tahira Kootbodien, Asuncion Mejias, Justin R Ortiz, Renato T Stein, Tina V Hartert	
18.	[Spotlight] Louis Bont – leading efforts to find an RSV vaccine	Tony Kirby	
19.	[Comment] ECMO: more than just a bridge over troubled waters?	Ryan Ruiyang Ling, Kollengode Ramanathan, Kiran Shekar	
20.	[Comment] Continuing ECMO with no possible transition to recovery or transplant	Alexander Supady, William L Allen, Thaddeus M Pope	
21.	[Comment] Easing the stress of chronic cough	Marta Dąbrowska, Lorcan McGarvey	
22.	[Articles] Efficacy and safety of gefapixant in women with chronic cough and cough-induced stress urinary incontinence: a phase 3b, randomised, multicentre, double-blind, placebo-controlled trial	Surinder S Birring, Linda Cardozo, Roger Dmochowski, Peter Dicpinigaitis, Amna Afzal, Carmen La Rosa, Susan Lu, Allison Martin Nguyen, Ruji Yao, Paul A Reyfman	
23.	[Position Paper] An international consensus on the use of asthma biologics in pregnancy	Jennifer Naftel, David J Jackson, Matthew Coleman, Grainne d'Ancona, Liam G Heaney, Paddy Dennison, Apostolos Bossios, Hitasha Rupani	
24.	[Comment] Navigating uncertainty: asthma biologics during pregnancy	Imran Howell, Aleksandra Howell, Ian Pavord	
25.	[Comment] Expanding the indication of CFTR modulator combinations for people with cystic fibrosis with non-F508del variants	Pierre-Régis Burgel	
26.	[Articles] Evaluation of elexacaftor–tezacaftor–ivacaftor treatment in individuals with cystic fibrosis and CFTRN1303K in the USA: a prospective, multicentre, open-label, single-arm trial	George M Solomon, Rachel W Linnemann, Rachel Rich, Ashleigh Streby, Brian Buehler, Eric Hunter, Kadambari Vijaykumar, William R Hunt, John J Brewington, Andras Rab, Shasha P Bai, Adrianna L Westbrook, Carmel McNicholas-Bevensee, Jong Hong, Candela Manfredi, Cristina Barilla, Shingo Suzuki, Brian R Davis, Eric J Sorscher	
27.	[News] The UK COVID-19 Inquiry and critical care	Priya Venkatesan	
28.	[Spotlight] One lung but many laughs at the Edinburgh Festival Fringe	Peter Ranscombe	
29.	[Spotlight] Saving lives with oxygen and monocytes at Edinburgh Fringe	Peter Ranscombe	
30.	[Comment] New thinking and a new direction in bronchiectasis	Ian D Pavord	
31.	[Spotlight] Fatal dyspnoea at the Palace of Versailles	Emmanuel Drouin, Serge Wasersztrum, Arnaud Chambellan	
32.	[Articles] Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab–ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trial	Yoshimasa Shiraishi, Shogo Nomura, Shunichi Sugawara, Hidehito Horinouchi, Yasuto Yoneshima, Hidetoshi Hayashi, Koichi Azuma, Satoshi Hara, Seiji Niho, Ryo Morita, Masafumi Yamaguchi, Toshihide Yokoyama, Kiyotaka Yoh, Takayasu Kurata, Hiroaki Okamoto, Masaki Okamoto, Takashi Kijima, Kazuo Kasahara, Yutaka Fujiwara, Shuji Murakami, Shintaro Kanda, Hiroaki Akamatsu, Shinnosuke Takemoto, Hiroyasu Kaneda, Toshiyuki Kozuki, Masahiko Ando, Yuta Sekino, Haruhiko Fukuda, Yuichiro Ohe, Isamu Okamoto	
33.	[Comment] Anti-CTLA-4 in non-small-cell lung cancer: insights from the NIPPON study	Molly S C Li, Stephanie P L Saw, Alfredo Addeo	
34.	[Articles] The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study	Pierre-Régis Burgel, Isabelle Sermet-Gaudelus, Emmanuelle Girodon, Isabelle Durieu, Véronique Houdouin, Camille Audousset, Julie Macey, Dominique Grenet, Michele Porzio, Marlène Murris-Espin, Philippe Reix, Mélisande Baravalle, Chantal Belleguic, Laurent Mely, Juliette Verhille, Laurence Weiss, Martine Reynaud-Gaubert, Marie Mittaine, Rebecca Hamidfar, Sophie Ramel, Laure Cosson, Benoit Douvry, Isabelle Danner-Boucher, Pierre Foucaud, Charlotte Roy, Espérie Burnet, Caroline Raynal, Marie-Pierre Audrezet, Jennifer Da Silva, Clémence Martin, French Cystic Fibrosis Reference Network study group	
35.	[Comment] Compassionate use trials and equitable access to variant-specific treatment for cystic fibrosis	Katherine Odem-Davis, Jennifer L Taylor-Cousar	
36.	[Articles] High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial	Jiayi Yu, Leilei Jiang, Lina Zhao, Xue Yang, Xiaomin Wang, Dan Yang, Minglei Zhuo, Hanxiao Chen, Wei Huang, Zhengfei Zhu, Min Zhang, Yipeng Song, Quanfu Li, Zhanshu Ma, Qifeng Wang, Yanli Qu, Rong Yu, Huiming Yu, Jun Zhao, Anhui Shi, Trial Management Group	
37.	[Comment] New strategies for patients with limited-stage small-cell lung cancer	Famke L Schneiders, Suresh Senan	
38.	[Correspondence] Sedation targets in the ICU: thinking beyond protocols	Bruna Brandao Barreto, Mariana Luz, Dimitri Gusmao-Flores	
39.	[Health-care Development] Interactions between respiratory syncytial virus and Streptococcus pneumoniae in the pathogenesis of childhood respiratory infections: a systematic review	Sjanna B Besteman, Debby Bogaert, Louis Bont, Asuncion Mejias, Octavio Ramilo, Daniel M Weinberger, Ron Dagan	
40.	[Spotlight] James Chalmers: A maverick making an impact in bronchiectasis	Peter Ranscombe	
41.	[Review] Rethinking bronchiectasis as an inflammatory disease	Merete B Long, Sanjay H Chotirmall, Michal Shteinberg, James D Chalmers	
42.	[Review] Biological and therapeutic implications of the cancer-related germline mutation landscape in lung cancer	Emmanouil Panagiotou, Ioannis A Vathiotis, Periklis Makrythanasis, Fred Hirsch, Triparna Sen, Konstantinos Syrigos	

更新于 2 分钟前

近期历史最近 100 条记录

2024-09-20	[Comment] Serotonin pathway blockade in pulmonary arterial hypertension	Marcin Kurzyna	
2024-09-20	[Articles] Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial	Olivier Sitbon, Andris Skride, Jeremy Feldman, Sandeep Sahay, Oksana A Shlobin, Vallerie McLaughlin, Hossein-Ardeschir Ghofrani, David Langleben, Ed Parsley, Gwyn D'Souza, Tonya Marmon, Watiri Kamau-Kelley, Renee Jones, Ravi Grewal, Steve Wring, Michelle	
2024-09-19	[Articles] Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial	Ze-Rui Zhao, Shi-Liang Liu, Ting Zhou, Gang Chen, Hao Long, Xiao-Dong Su, Xu Zhang, Jian-Hua Fu, Peng Lin, Lan-Jun Zhang, Tie-Hua Rong, Jia-Di Wu, Zhi-Chao Li, Hui-Lin Su, Ji-Yang Chen, Yun-Peng Yang, Yong-Bin Lin, Mian Xi, Hong Yang	
2024-09-19	[Comment] Stereotactic body radiotherapy plus neoadjuvant chemoimmunotherapy in operable non-small-cell lung cancer	Rafał Dziadziuszko, Bartłomiej Tomasik	
2024-09-17	[Editorial] Extreme heat: holistic thinking in respiratory medicine	The Lancet Respiratory Medicine	
2024-09-13	[Correspondence] Top ten research priorities for sepsis research: UK James Lind Alliance priority setting partnership	Joanne McPeake, Mark Oakes, Colin Graham, Nahid Ahmad, Nazir Lone, Bronwen Connolly, James Lind Alliance Sepsis PSP Steering Group	
2024-09-11	[Articles] Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory st	Yongfeng Yu, Qisen Guo, Yongchang Zhang, Jian Fang, Diansheng Zhong, Baogang Liu, Pinhua Pan, Dongqing Lv, Lin Wu, Yanqiu Zhao, Juan Li, Zhihua Liu, Chunling Liu, Haichuan Su, Yun Fan, Tongmei Zhang, Anwen Liu, Bo Jin, Ye Wang, Jianying Zhou, Zhihong Zhan	
2024-09-11	[Comment] Savolitinib in NSCLC: progress in the MET exon 14 journey	Tetsuya Mitsudomi	
2024-09-10	[Articles] Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months	Charles S Haworth, Michal Shteinberg, Kevin Winthrop, Alan Barker, Francesco Blasi, Katerina Dimakou, Lucy C Morgan, Anne E O'Donnell, Felix C Ringshausen, Oriol Sibila, Rachel M Thomson, Kevin J Carroll, Federica Pontenani, Paola Castellani, James D Chal	
2024-09-10	[Comment] PROMISing results for inhaled antibiotics in bronchiectasis	Marta María García Clemente, Guillermo Suárez Cuartín	
2024-09-10	[Articles] Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled tr	Baohui Han, Trevor Feinstein, Yuankai Shi, Gongyan Chen, Yu Yao, Chunhong Hu, Jianhua Shi, Jifeng Feng, Huijuan Wu, Ying Cheng, Qi-sen Guo, Zhijun Jie, Feng Ye, Yiping Zhang, Zhihua Liu, Weidong Mao, Liangming Zhang, Junguo Lu, Jun Zhao, Lyudmila Bazhenov	
2024-09-10	[Comment] Plinabulin, a microtubule destabilising agent, in non-small-cell lung cancer: lessons from the DUBLIN-3 trial	Rafael Rosell, María González-Cao, Miguel Angel Molina-Vila	
2024-09-09	[Articles] Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial	Irene J Higginson, Sarah T Brown, Adejoke O Oluyase, Peter May, Matthew Maddocks, Massimo Costantini, Sabrina Bajwah, Charles Normand, Claudia Bausewein, Steffen T Simon, Karen Ryan, David C Currow, Miriam J Johnson, Simon P Hart, Hannah Mather, Malgorzat	
2024-09-09	[Comment] The ongoing battle against breathlessness	Kris Mooren, Huib A M Kerstjens	
2024-09-09	[Comment] Choice overload for RSV prevention—how to form your opinion	Natasha Halasa, Louis Bont	
2024-09-09	[Spotlight] Louis Bont – leading efforts to find an RSV vaccine	Tony Kirby	
2024-09-09	[Series] Early-life respiratory syncytial virus disease and long-term respiratory health	Heather J Zar, Ferdinand Cacho, Tahira Kootbodien, Asuncion Mejias, Justin R Ortiz, Renato T Stein, Tina V Hartert	
2024-09-09	[Series] Respiratory syncytial virus infections in adults: a narrative review	Joanne G Wildenbeest, David M Lowe, Joseph F Standing, Christopher C Butler	
2024-09-05	[Comment] ECMO: more than just a bridge over troubled waters?	Ryan Ruiyang Ling, Kollengode Ramanathan, Kiran Shekar	
2024-09-05	[Comment] Continuing ECMO with no possible transition to recovery or transplant	Alexander Supady, William L Allen, Thaddeus M Pope	
2024-08-31	[Articles] Efficacy and safety of gefapixant in women with chronic cough and cough-induced stress urinary incontinence: a phase 3b, randomised, multicentre, double-blind, placebo-controlled trial	Surinder S Birring, Linda Cardozo, Roger Dmochowski, Peter Dicpinigaitis, Amna Afzal, Carmen La Rosa, Susan Lu, Allison Martin Nguyen, Ruji Yao, Paul A Reyfman	
2024-08-31	[Comment] Easing the stress of chronic cough	Marta Dąbrowska, Lorcan McGarvey	
2024-08-29	[Position Paper] An international consensus on the use of asthma biologics in pregnancy	Jennifer Naftel, David J Jackson, Matthew Coleman, Grainne d'Ancona, Liam G Heaney, Paddy Dennison, Apostolos Bossios, Hitasha Rupani	
2024-08-29	[Comment] Navigating uncertainty: asthma biologics during pregnancy	Imran Howell, Aleksandra Howell, Ian Pavord	
2024-08-27	[Comment] Expanding the indication of CFTR modulator combinations for people with cystic fibrosis with non-F508del variants	Pierre-Régis Burgel	
2024-08-27	[Articles] Evaluation of elexacaftor–tezacaftor–ivacaftor treatment in individuals with cystic fibrosis and CFTRN1303K in the USA: a prospective, multicentre, open-label, single-arm trial	George M Solomon, Rachel W Linnemann, Rachel Rich, Ashleigh Streby, Brian Buehler, Eric Hunter, Kadambari Vijaykumar, William R Hunt, John J Brewington, Andras Rab, Shasha P Bai, Adrianna L Westbrook, Carmel McNicholas-Bevensee, Jong Hong, Candela Manfred	
2024-08-22	[News] The UK COVID-19 Inquiry and critical care	Priya Venkatesan	
2024-08-22	[Spotlight] One lung but many laughs at the Edinburgh Festival Fringe	Peter Ranscombe	
2024-08-22	[Spotlight] Saving lives with oxygen and monocytes at Edinburgh Fringe	Peter Ranscombe	
2024-08-21	[Comment] New thinking and a new direction in bronchiectasis	Ian D Pavord	
2024-08-17	[Articles] Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab–ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, rando	Yoshimasa Shiraishi, Shogo Nomura, Shunichi Sugawara, Hidehito Horinouchi, Yasuto Yoneshima, Hidetoshi Hayashi, Koichi Azuma, Satoshi Hara, Seiji Niho, Ryo Morita, Masafumi Yamaguchi, Toshihide Yokoyama, Kiyotaka Yoh, Takayasu Kurata, Hiroaki Okamoto, Mas	
2024-08-17	[Spotlight] Fatal dyspnoea at the Palace of Versailles	Emmanuel Drouin, Serge Wasersztrum, Arnaud Chambellan	
2024-08-17	[Comment] Anti-CTLA-4 in non-small-cell lung cancer: insights from the NIPPON study	Molly S C Li, Stephanie P L Saw, Alfredo Addeo	
2024-08-15	[Editorial] FLiRTing with danger as SARS-CoV-2 variants evolve	The Lancet Respiratory Medicine	
2024-08-14	[Comment] Compassionate use trials and equitable access to variant-specific treatment for cystic fibrosis	Katherine Odem-Davis, Jennifer L Taylor-Cousar	
2024-08-14	[Articles] The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study	Pierre-Régis Burgel, Isabelle Sermet-Gaudelus, Emmanuelle Girodon, Isabelle Durieu, Véronique Houdouin, Camille Audousset, Julie Macey, Dominique Grenet, Michele Porzio, Marlène Murris-Espin, Philippe Reix, Mélisande Baravalle, Chantal Belleguic, Laurent	
2024-08-13	[Articles] High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial	Jiayi Yu, Leilei Jiang, Lina Zhao, Xue Yang, Xiaomin Wang, Dan Yang, Minglei Zhuo, Hanxiao Chen, Wei Huang, Zhengfei Zhu, Min Zhang, Yipeng Song, Quanfu Li, Zhanshu Ma, Qifeng Wang, Yanli Qu, Rong Yu, Huiming Yu, Jun Zhao, Anhui Shi, Trial Management Grou	
2024-08-13	[Comment] New strategies for patients with limited-stage small-cell lung cancer	Famke L Schneiders, Suresh Senan	
2024-08-09	[Comment] Patient-reported outcomes: missing in asthma remission	Amy Hai Yan Chan, Paul Leong, John Politis, Vanessa M McDonald, Philip Bardin	
2024-08-08	[Articles] Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study	Margaux M I Meslé, Jeremy Brown, Piers Mook, Mark A Katz, José Hagan, Roberta Pastore, Bernhard Benka, Monika Redlberger-Fritz, Nathalie Bossuyt, Veerle Stouten, Catharina Vernemmen, Elisabet Constantinou, Marek Maly, Jan Kynčl, Ondrej Sanca, Tyra Grove K	
2024-08-08	[Comment] Impact of COVID-19 vaccination programmes in Europe: lives saved and lessons learned	Oliver J Watson, Alexandra B Hogan	
2024-08-02	[News] US FDA approves menthol e-cigarette products	Bryant Furlow	
2024-07-24	[Comment] Foritinib, a type II ROS1 inhibitor for NSCLC	Jii Bum Lee, Sai-Hong Ignatius Ou	
2024-07-24	[Articles] Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study	Jin-Ji Yang, Jianying Zhou, Si-Yang Maggie Liu, Mingjun Li, Zhiye Zhang, Ying Cheng, Yun Fan, Hongming Pan, Baoqing Wang, Gongyan Chen, Ke Wang, Liyan Jiang, Yanping Hu, Jianhua Shi, Xiaorong Dong, Cuimin Ding, Yunpeng Liu, Zhe Liu, Wangjun Liao, Wei Li,	
2024-07-20	[Correspondence] Sedation targets in the ICU: thinking beyond protocols	Bruna Brandao Barreto, Mariana Luz, Dimitri Gusmao-Flores	
2024-07-17	[News] US Supreme Court overturns Chevron doctrine	Bryant Furlow	
2024-07-16	[Articles] Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validation	Hernan P Fainberg, Yuben Moodley, Isaac Triguero, Tamera J Corte, Jannie M B Sand, Diana J Leeming, Morten A Karsdal, Athol U Wells, Elisabetta Renzoni, John Mackintosh, Dino B A Tan, Roger Li, Joanne Porte, Rebecca Braybrooke, Gauri Saini, Simon R Johnso	
2024-07-16	[Review] Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients	Simon Feys, Agostinho Carvalho, Cornelius J Clancy, Jean-Pierre Gangneux, Martin Hoenigl, Katrien Lagrou, Bart J A Rijnders, Laura Seldeslachts, Lore Vanderbeke, Frank L van de Veerdonk, Paul E Verweij, Joost Wauters	
2024-07-16	[Comment] Biomarker-defined endotypes of pulmonary fibrosis	A Scott McCall, Jonathan A Kropski	
2024-07-13	[Spotlight] Alin Gragossian: from emergency medicine resident to heart transplant recipient	Tony Kirby	
2024-07-12	[Articles] Nasal sprays and behavioural interventions compared with usual care for acute respiratory illness in primary care: a randomised, controlled, open-label, parallel-group trial	Paul Little, Jane Vennik, Kate Rumsby, Beth Stuart, Taeko Becque, Michael Moore, Nick Francis, Alastair D Hay, Theo Verheij, Katherine Bradbury, Kate Greenwell, Laura Dennison, Sian Holt, James Denison-Day, Ben Ainsworth, James Raftery, Tammy Thomas, Chri	
2024-07-12	[Comment] Treating acute respiratory illness: the need to be proactive	Evangelos J Giamarellos-Bourboulis	
2024-07-10	[Spotlight] Fasting in Ramadan and respiratory diseases	Talha Burki	
2024-07-09	[Health-care Development] Interactions between respiratory syncytial virus and Streptococcus pneumoniae in the pathogenesis of childhood respiratory infections: a systematic review	Sjanna B Besteman, Debby Bogaert, Louis Bont, Asuncion Mejias, Octavio Ramilo, Daniel M Weinberger, Ron Dagan	
2024-07-09	[Spotlight] James Chalmers: A maverick making an impact in bronchiectasis	Peter Ranscombe	
2024-07-04	[Review] Rethinking bronchiectasis as an inflammatory disease	Merete B Long, Sanjay H Chotirmall, Michal Shteinberg, James D Chalmers	
2024-06-21	[News] Whooping cough cases rising	Priya Venkatesan	
2024-06-15	[Review] Biological and therapeutic implications of the cancer-related germline mutation landscape in lung cancer	Emmanouil Panagiotou, Ioannis A Vathiotis, Periklis Makrythanasis, Fred Hirsch, Triparna Sen, Konstantinos Syrigos	
2024-06-15	[Correspondence] Potential for personalised and biomarker-guided COPD self-treatment approaches	Anke Lenferink, Emanuel Citgez, Paul D L P M van der Valk, Job van der Palen, Tanja W Effing, Marjolein G J Brusse-Keizer	
2024-06-14	[Comment] Moving forward in IPF: lessons learned from clinical trials	Ganesh Raghu, Thomas R Fleming	
2024-06-13	[Correspondence] Challenges of modulating the risk of bronchopulmonary dysplasia in clinical trials	Brady Thomas, Patrick McNamara, Jennifer Bermick	
2024-06-13	[Correspondence] Challenges of modulating the risk of bronchopulmonary dysplasia in clinical trials – Authors' reply	John Lowe, Janet Berrington, David Gillespie, Mark Turner, Sailesh Kotecha	
2024-06-12	[Articles] Hypothermia for expanded criteria organ donors in kidney transplantation in France (HYPOREME): a multicentre, randomised controlled trial	The HYPOREME Trial Group	
2024-06-12	[Comment] Mild hypothermia for expanded criteria kidney donors: balancing evidence and uncertainty	Riccardo Campi, Vincenzo Li Marzi, Sergio Serni	
2024-06-12	[News] 2024 American Thoracic Society International Conference	Priya Venkatesan	
2024-06-11	[Articles] Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial	Ziming Li, Xiaomin Dang, Dingzhi Huang, Shi Jin, Weiwei Li, Jianhua Shi, Xicheng Wang, Yiping Zhang, Zhengbo Song, Junping Zhang, Wu Zhuang, Xuewen Liu, Liyan Jiang, Xiangjiao Meng, Mingfang Zhao, Jianying Zhou, Liangming Zhang, Pingli Wang, Hui Luo, Junq	
2024-06-11	[Comment] Tackling KRASG12C-mutated non-small-cell lung cancer: iteration and exploration	Jia Luo, Liza C Villaruz	
2024-06-06	[Spotlight] Protecting respiratory health of athletes: an Olympic challenge	James H Hull, Hege Clemm, Vibeke Backer, Michael Koehle, Margo Mountjoy, Martin Schwellnus, J Tod Olin	
2024-06-06	[Articles] Long-term outcomes of early exposure to repeated general anaesthesia in children with cystic fibrosis (CF-GAIN): a multicentre, open-label, randomised controlled phase 4 trial	Claire Elizabeth Wainwright, Suzanna Vidmar, Vicki Anderson, Pierrick Bourgeat, Catherine Byrnes, John Brooke Carlin, Joyce Cheney, Peter Cooper, Andrew Davidson, Nicholas Gailer, Jasmin Grayson-Collins, Alexandra Quittner, Colin Robertson, Olivier Salvad	
2024-06-06	[Spotlight] Living with spinal muscular atrophy while working in critical care	Linsey Wehner, Atul Malhotra, Jeremy Orr	
2024-06-06	[Comment] Early exposure to general anaesthesia: considerations for age-related vulnerability and behavioural outcomes	Daniil P Aksenov	
2024-06-06	[Editorial] Respiratory syncytial virus vaccines: the future is bright	The Lancet Respiratory Medicine	
2024-05-25	[Personal View] When to intubate in acute hypoxaemic respiratory failure? Options and opportunities for evidence-informed decision making in the intensive care unit	Kevin G Lee, Oriol Roca, Jonathan D Casey, Matthew W Semler, Georgiana Roman-Sarita, Christopher J Yarnell, Ewan C Goligher	
2024-05-22	[Articles] High-flow nasal oxygen for children's airway surgery to reduce hypoxaemic events: a randomised controlled trial	Susan Humphreys, Britta S von Ungern-Sternberg, Fiona Taverner, Andrew Davidson, Justin Skowno, Ben Hallett, David Sommerfield, Neil Hauser, Tara Williams, Susan Spall, Trang Pham, Tiffany Atkins, Mark Jones, Emma King, Laura Burgoyne, Philip Stephens, Sh	
2024-05-22	[Corrections] Correction to Lancet Respir Med 2024; 12: 207–16		
2024-05-22	[Corrections] Correction to Lancet Respir Med 2024; 12: 183–85		
2024-05-22	[Comment] Paediatric anaesthesia: it is not only what you do, but how you do it	Thomas Engelhardt, Nicola Disma	
2024-05-18	[Comment] Continuous positive airway pressure is here to stay	Atul Malhotra, Jeremy H Pettus	
2024-05-18	[Comment] Re-evaluating the role of CPAP in OSA management amid obesity pharmacology advancements	Neomi Shah	
2024-05-11	[Viewpoint] Leveraging the pleural space for anticancer therapies in pleural mesothelioma	Kevin G Blyth, Prasad S Adusumilli, Philippe Astoul, Liz Darlison, Y C Gary Lee, Aaron S Mansfield, Stefan J Marciniak, Nick Maskell, Vasiliki Panou, Tobias Peikert, Najib M Rahman, Marjorie G Zauderer, Daniel Sterman, Dean A Fennell	
2024-05-11	[Articles] Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial	Eric Lim, David Waller, Kelvin Lau, Jeremy Steele, Anthony Pope, Clinton Ali, Rocco Bilancia, Manjusha Keni, Sanjay Popat, Mary O'Brien, Nadza Tokaca, Nick Maskell, Louise Stadon, Dean Fennell, Louise Nelson, John Edwards, Sara Tenconi, Laura Socci, Rober	
2024-05-11	[Comment] MARS 2 trial: the future of pleurectomy decortication in pleural mesothelioma	Federica Grosso, Luigi Cerbone, Alessandra Curioni-Fontecedro	
2024-05-09	[Comment] Overcoming barriers to scaling up tuberculosis preventive treatment for household contacts	Gavin Churchyard, Nicole Salazar-Austin	
2024-05-09	[Articles] Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies	Leonardo Martinez, James A Seddon, C Robert Horsburgh, Christoph Lange, Anna M Mandalakas, TB Contact Studies Consortium	
2024-05-09	[Editorial] Tackling health disparities in asthma: a life-course challenge	The Lancet Respiratory Medicine	
2024-05-03	[Articles] Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial	Robert P Frantz, Vallerie V McLaughlin, Sandeep Sahay, Pilar Escribano Subías, Ronald L Zolty, Raymond L Benza, Richard N Channick, Kelly M Chin, Anna R Hemnes, Luke S Howard, Olivier Sitbon, Jean-Luc Vachiéry, Roham T Zamanian, Matt Cravets, Robert F Ros	
2024-05-01	[Comment] Treatment effects on functional outcomes in trials with severely ill patients	Edmond S W Ng	
2024-05-01	[Articles] Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial	Matthew F Mart, Leanne M Boehm, Amy L Kiehl, Michelle N Gong, Atul Malhotra, Robert L Owens, Babar A Khan, Margaret A Pisani, Gregory A Schmidt, R Duncan Hite, Matthew C Exline, Shannon S Carson, Catherine L Hough, Peter Rock, Ivor S Douglas, Daniel J Fei	
2024-04-26	[Articles] Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial	John Lowe, David Gillespie, Ali Aboklaish, Tin Man Mandy Lau, Claudia Consoli, Malavika Babu, Mark Goddard, Kerenza Hood, Nigel Klein, Emma Thomas-Jones, Mark Turner, Marie Hubbard, Julian Marchesi, Janet Berrington, Sailesh Kotecha	
2024-04-26	[Comment] Azithromycin for the prevention of chronic lung disease of prematurity: not a silver bullet	Abdul Razak	
2024-04-26	[News] US EPA confronts chemical plants’ deadly air pollution	Bryant Furlow	
2024-04-25	[Personal View] Chronic respiratory disease in Indigenous peoples: a framework to address inequity and strengthen respiratory health and health care globally	Anne B Chang, Tom Kovesi, Gregory J Redding, Conroy Wong, Gonzalo G Alvarez, Rebecca Nantanda, Edgar Beltetón, Maynor Bravo-López, Maree Toombs, Paul J Torzillo, Diane M Gray	
2024-04-19	[Articles] Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo	Sascha Meyer, Johannes Bay, Axel R Franz, Harald Ehrhardt, Lars Klein, Jutta Petzinger, Christoph Binder, Susanne Kirschenhofer, Anja Stein, Britta Hüning, Axel Heep, Eva Cloppenburg, Julia Muyimbwa, Torsten Ott, Julia Sandkötter, Norbert Teig, Susanne Wi	
2024-04-19	[Comment] Vitamin A and bronchopulmonary dysplasia: the next steps	Abhijeet Rakshasbhuvankar, J Jane Pillow	
2024-04-19	[News] New report outlines cost of inaction on AMR ahead of UN high-level meeting	Talha Burki	
2024-04-18	[Editorial] Lung transplant donors: barriers and ethical considerations	The Lancet Respiratory Medicine	
2024-04-17	[Articles] Transbronchial cryobiopsy followed by as-needed surgical lung biopsy versus immediate surgical lung biopsy for diagnosing interstitial lung disease (the COLD study): a randomised controlled trial	Kirsten A Kalverda, Maarten K Ninaber, Lizzy Wijmans, Jan von der Thüsen, René E Jonkers, Johannes M Daniels, Jelle R Miedema, Chris Dickhoff, Jürgen Hölters, David Heineman, Merijn Kant, Teodora Radonic, Ghada Shahin, Danielle Cohen, Bart Boerrigter, Suz	
2024-04-17	[Comment] Optimising the approach to ILD diagnosis: the balance of procedural complications against diagnostic accuracy	Margaret L Salisbury, Kevin R Flaherty	
2024-04-16	[News] European Lung Cancer Congress 2024	Priya Venkatesan	
2024-04-11	[Correspondence] Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway	Nhung TH Trinh, Annika M Jödicke, Martí Català, Núria Mercadé-Besora, Saeed Hayati, Angela Lupattelli, Daniel Prieto-Alhambra, Hedvig ME Nordeng	